In addition, a few of the panel TAAs, including CIP2A/p90, had a high diagnostic performance in the detection of cancers, especially for the patients at early stage (Zhang et al., 2016; Wang X et al., 2019; Table 3). The gene discussed is CIP2A; the disease is cancer.